BOLT
Bolt Biotherapeutics, Inc.Company with tickers: BOLT
Market Cap
$7.69M
Shares Outstanding
1,921,567
CIK
1641281
Website
Visit website
Investor Relations
Investor relations
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-06-11 | — | |
| 10-Q | 2026-05-12 | 2026-03-31 | |
| 8-K | 2026-05-12 | — | |
| DEF 14A | 2026-04-28 | 2026-04-27 | |
| 8-K | 2026-03-12 | — | |
| 10-K | 2026-03-12 | 2025-12-31 | |
| 10-Q | 2025-11-12 | 2025-09-30 | |
| 8-K | 2025-11-12 | — | |
| 8-K | 2025-10-02 | 2025-10-01 | |
| 8-K | 2025-08-14 | — | |
| 10-Q | 2025-08-14 | 2025-06-30 | |
| 8-K | 2025-06-06 | — | |
| 8-K | 2025-06-04 | — | |
| 8-K | 2025-05-28 | 2025-05-27 | |
| 8-K | 2025-05-12 | — | |
| 10-Q | 2025-05-12 | 2025-03-31 | |
| DEF 14A | 2025-04-25 | 2025-05-27 | |
| 8-K | 2025-04-16 | 2025-04-15 | |
| DEF 14A | 2025-04-15 | 2025-05-27 | |
| 10-K | 2025-03-24 | 2024-12-31 | |
| 8-K | 2025-03-24 | — | |
| 8-K | 2025-01-03 | 2025-01-02 | |
| 8-K | 2024-12-23 | — | |
| 8-K | 2024-11-12 | — | |
| 10-Q | 2024-11-12 | 2024-09-30 | |
| 8-K | 2024-09-04 | 2024-08-28 | |
| 10-Q | 2024-08-13 | 2024-06-30 | |
| 8-K | 2024-08-13 | — | |
| 8-K | 2024-07-03 | 2024-07-02 | |
| 8-K | 2024-06-14 | 2024-06-12 | |
| 8-K | 2024-05-14 | 2024-05-13 | |
| 10-Q | 2024-05-14 | 2024-03-31 | |
| DEF 14A | 2024-04-26 | 2024-06-12 | |
| 8-K | 2024-03-21 | — | |
| 10-K | 2024-03-21 | 2023-12-31 | |
| 10-Q | 2023-11-09 | 2023-09-30 | |
| 8-K | 2023-11-09 | — | |
| 10-Q | 2023-08-07 | 2023-06-30 | |
| 8-K | 2023-08-07 | — | |
| 8-K | 2023-06-13 | 2023-06-12 | |
| 8-K | 2023-05-11 | — | |
| 10-Q | 2023-05-11 | 2023-03-31 | |
| DEF 14A | 2023-04-28 | 2023-06-12 | |
| 8-K | 2023-03-29 | — | |
| 10-K | 2023-03-29 | 2022-12-31 | |
| 8-K | 2022-12-14 | — | |
| 8-K | 2022-11-10 | — | |
| 10-Q | 2022-11-10 | 2022-09-30 | |
| 10-Q | 2022-08-10 | 2022-06-30 | |
| 8-K | 2022-08-10 | — |
Showing 1–50 of 71 filings